Update of Oncho Program Status. Kofi Marfo

Similar documents
Neglected Zoonoses in Public Health Perspectives

Inter-Agency Donor Group meeting Hunger, Health and Climate Change: prioritizing research effort in the livestock sector

Module 1. Introduction to Targeted Neglected Tropical Diseases (NTDs)

A review of Filariasis

Module 6. Monitoring and Evaluation (M&E)

Environmental Health Assessment of Difference in Manifestation of Onchocerciasis among Residents of Okigwe in Nigeria

NEWSLETTER. ACTION AGAINST WORMS RE-LAUNCHING ACTION AGAINST WORMS

Drug Discovery: Supporting development of new drugs to treat global parasitic diseases

Summary of the Eighteenth Meeting of the International Task Force for Disease Eradication (II) April 6, 2011

IN THIS ISSUE: What should programme managers know when they are treating young children? Your response has been overwhelmingly positive.

Update on the global status of the donation managed by WHO of the medicines for preventive chemotherapy (PC)

KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY, KUMASI COLLEGE OF HEALTH SCIENCES SCHOOL OF MEDICAL SCIENCES DEPARTMENT OF CLINICAL MICROBIOLOGY

The Biology and Control of Human Onchocerciasis Prof. Emeritus Ed Cupp


WORLD HEATH ORGANIZATION GLOBAL PROGRAMME TO ELIMINATE LYMPHATIC FILARIASIS

Elephantiasis. C h r i s t i a n H e s s. N u t r i t i o n R o n V e r n o n

Combating onchocerciasis in Africa after 2002: the place of vector control

THE IMPACT OF IVERMECTIN MASS DRUG ADMINISTRATION ON THE LEVEL OF ENDEMICITY AND INTENSITY OF ONCHOCERCA VOLVULUS

Drug therapy of Filariasis. Dr. Shareef sm Asst. professor pharmacology

LYMPHATIC FILARIASIS WORLD HEALTH ORGANIZATION GLOBAL PROGRAMME TO ELIMINATE LYMPHATIC FILARIASIS. A HanDbook for national elimination programmes

Sindew Mekasha Feleke, 1 Gemechu Tadesse, 1 Kalkidan Mekete, 1 Afework Hailemariam Tekle, 2 and Amha Kebede Introduction

Chapter 9. General discussion

Creating a global community for clinical drug repurposing and development. Leonard Sacks Center for drug evaluation and research FDA

Department of Microbio

Vector Control in emergencies

FULL LENGTH RESEARCH ARTICLE

Onchocerciasis Control in South Eastern Nigeria: Prevalence Survey and Community-based Mass Distribution of Ivermectin. O.C.

TISSUE NEMATODES MODULE 49.1 INTODUCTION OBJECTIVES 49.2 FILARIASIS. Notes

NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME (NVBDCP)

THE CONTROL AND SURVEILLANCE OF FILARIASIS IN HAINAN PROVINCE, CHINA

Elimination of Lymphatic Filariasis in the South-East Asia Region

GLOBAL CONFERENCE Global elimination of dog-mediated human rabies The Time Is Now

Rabies Control Projects in Bangladesh: Current Efforts by Global HealthShare (GHS) Initiative and Humanity Beyond Barriers (HBB)

Peter J. Weina, PhD, MD, FACP, FIDSA Colonel, Medical Corps, US Army Deputy Commander, WRAIR

Management And Treatment Of Tropical Diseases By B. G. Maegraith

Rabies Research & Impact

Dracunculiasis, Onchocerciasis, Schistosomiasis, and Trachoma

WINNING THE WAR AGAINST WORMS

Onchocerciasis & Lymphatic Filariasis Global Health & Disasters Course UCHSC

M Correia, D Amonkar, P Audi, C Bhat, P Cruz, N Mitta, A Pednekar, P Kurane

Dogs in the Workplace: Benefits and Potential Challenges

Community-based syndromic surveillance-response in Chad

Reducing the incidence of malaria

Rabies Control in China

DRACUNCULIASIS, ONCHOCERCIASIS, SCHISTOSOMIASIS,

WHO Programme for International Drug Monitoring. Shanthi Pal Quality Assurance and Safety of Medicines World Health Organization

Lymphatic Filariasis Elimination Programme

Large, dark brown or black with dark eyes Adult females feed on blood; adult males feed on nectar Vector for Equine Infectious Anemia

Rabies in Morocco Current national policy situation and conformity with guidlines

An evaluation study of mass drug administration of DEC tablet in a North-Eastern district of Andhra Pradesh

A splendid gift from the Earth: the origins & impact of Avermectin

Justina E. Ogbuokiri, Takemi Fellow Final Report July 24th 1995

Report by the Director-General

Drug combinations against soiltransmitted

Ivermectin for malaria transmission control

Corallopyronin A: a new anti-filarial drug. Kenneth Pfarr Institute for Medical Microbiology, Immunology and Parasitology


Global Alliance for Rabies Control Annual Report. January to December 2017

School-based Deworming Interventions: An Overview

MODULE. Onchocerciasis. For the Ethiopian Health Center Team

AMR in AFRICA. Dr Marc Sprenger Director AMR Secretariat. Antimicrobial resistance in Africa

Albendazole for the control and elimination of lymphatic filariasis: systematic review

FOR LAGOS STATE UNIVERSITY WEBSITE. Academic Staff Bio Data

pissn: eissn:

WHO/FIU Distr.: Limited English only

TRYPANOSOMIASIS IN TANZANIA

First-year experiences in implementing Thailand s National Strategic Plan on AMR

Rabies free zone in Thailand. Dr. Pornpitak Panlar Bureau of General Communicable Disease Department of Disease Control

ZOONOSIS SURVEILLANCE SYSTEMS IN COTE D IVOIRE IN THE CONCEPT OF ONE HEALTH : STRENGTHS, CHALLENGES AND PERPECTIVES

How to improve quality of data for monitoring progress of rabies programmes?

14th Conference of the OIE Regional Commission for Africa. Arusha (Tanzania), January 2001

Dr Sumathy Puvanendiran, BVSc,M.Phil,PhD(USA) Veterinary Research Officer Dept of Animal Production & Health Sri Lanka

Using research to shape policy and practice. Dr Athman Mwatondo

Impact of neglected diseases on animal productivity and public health in Africa

IMPACT OF NEGLECTED DISEASES ON ANIMAL PRODUCTIVITY AND PUBLIC HEALTH IN AFRICA

Filaria Journal. Open Access. Abstract. BioMed Central

BIO 221 Invertebrate Zoology I Spring Ancylostoma caninum. Ancylostoma caninum cuticular larval migrans. Lecture 23

FAO-OIE-WHO Tripartite Positions and Actions on Antimicrobial Resistance (AMR)

Tissue and Blood Residing Nematodes

INDONESIA COUNTRY REPORT

Dermatitis Caused by Simulium (Blackflies) Bite

Alternative mass drug administration regimens for Lymphatic Filariasis. Report of findings

THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER, ELDERLY AND CHILDREN

Public private partnerships in blindness prevention: reaching beyond the eye

OIE global strategy for rabies control, including regional vaccine banks

Evidence of continued transmission of Wuchereria bancrofti

Unit title: Livestock Husbandry, Health and Welfare (SCQF level 6)

EFFECT OF DOXYCYCLINE TREATMENT ON Onchocerca volvulus WORMS THAT RESPOND POORLY TO IVERMECTIN. Jubin Osei-Mensah BSc. (Hons)

ANIMAL RABIES IN NEPAL AND RACCOON RABIES IN ALBANY COUNTY, NEW YORK

Elimination of Lymphatic Filariasis in the South-East Asia Region

Bed bugs: What to do about unwanted houseguests

PROCEEDINGS OF THE ASSOCIATION OF INSTITUTIONS OF TROPICAL VETERINARY MEDICINE

Strengthening Epidemiology Capacity Using a One Health Framework in South Asia

Mosquito-borne Dog Heartworm Disease 1

Effectiveness of Educational Module on knowledge regarding Dengue and its prevention

Dog Population Management and Rabies Control

Lymphatic Filariasis

EMERGING AND RE-EMERGING ZOONOTIC PARASITES: PREVENTIVE AND CONTROL STRATEGIES

Regional Experience on VEEs and VSBs in South-East Asia (SEA)

Santa Clara County Vector Control District Operations and Surveillance Report February 2018

Transcription:

Update of Oncho Program Status Kofi Marfo

Presentation Outline Introduction Progress of Activities Achievements Challenges Way Forward

NTDs A group of about 17 infectious diseases which affect over a billion people world wide and most of whom live in extreme poverty Severely debilitating and disabling Endemic in poor communities Promotes poverty and intense stigma Concentrate in remote rural areas, urban slums or conflict zones

Neglected Tropical Disease (NTDs) Lymphatic Filariasis Onchocerciasis Schistomiasis Soil Transmitted Helminthes Trachoma Buruli ulcer Dracunculiasis Leprosy Rabies Human African Trypanosomiasis Leishmaniasis Yaws Cysticercosis Echinococcosis Dengue Chaga s disease Foodborne trematode infections

PCT NTDs Target in Ghana Ghana is endemic for all 5 NTDs which employ MDA for their control and elimination LF is endemic in 98 out of 216 districts (endemic pop about 12M) Onchocerciasis is endemic in 9 out of 10 regions (85 districts targeted) Trachoma is endemic in 2 regions - 37 districts SCH is mapped and endemic in all districts and regions STH is endemic in all districts (strategy is to deworm all SAC annually)

The Ghana NTD Map Upper west Upper East Northern Brong Ahafo Volta Ashanti Eastern Western Centra Greater Accra

Strategies Mass Drug Administration Morbidity Control and Management Health Education

Onchocerciasis Onchocerciasis also known as River Blindness Caused by filarial worm called Onchocerca volvulus Endemic in South America, Africa and Asia 2 types exist in Ghana Savannah Forest

Transmission Cycle Human infection begins with deposition of the infective larvae in the skin by the bite of an infected black fly (simulium damnosum) Larvae develops into adult worm which are found in the subcutaneous nodules Gravid adult female worm releases microfilariae (mf) Mf migrate out of the nodules through the tissues and concentrate in the dermis

Transmission of Oncho When female fly ingests mf from the host s skin and transmits to others these develop into infective larvae Life span of the adult worms is up to 15 yrs (av. 9 yrs) Blackfly breeds along fast flowing rivers and streams Biting and disease transmission is restricted to these locations

Disease presentation The most common symptom is itching, which is caused by the body s reaction to microfilariae and the following clinical signs: Skin disorders Nodules formation- often found over the bony Onchocercal dermatitis-small papules Lizard skin -areas of roughening Leopard skin -areas of depigmentation (esp. lower limbs) Ocular lesions which may lead to blindness

Nodules

The Onchocerciasis Disease These microscopic worms cause unbearable itching disfiguring skin disease blindness APOC/Impact/Team3/Caemroon PARE GILLES / SPECIAL TO THE VANCOUVER SUN

Snapshot of MDA/Oncho History MDA started in 1998 for all endemic districts under OCP As a control program, MDA was done only at the community level 2002 APOC was formed, MDA cont at the community level Loss of data so APOC org REMO in 2009 2015 ESPEN was formed, change from control to Elimination 2016 GOEC was formed 2017- Oncho Impact Assessment was done 2018 MDA implementation unit was changed from community to sub district level

Change in Oncho Prevalence Type of endemicity Number of districts being treated 2009- REMO Number of districts from 2013 2015 with epi results Hyper 15 0 Meso Hypo 29 41 2 83

Activities Oncho Impact Assessment-2017 Study Area 154 districts 85 endemic districts 15 hyper endemic 29 meso endemic 41 hypo endemic 50 hypo endemic districts 19 additional districts with reported endemicity based on epid surveys, blackfly nuisance and stopped LF treatment

Criteria for sites selected 312 sites selected 2 sites per districts; in a few cases 2 sites for 3 districts based on location of breeding site, river basin and district re-demarcation Communities closest to fly breeding site/river basin Communities within 5km of fly breeding site/river basin Large (pop > 500) urbanized communities excluded Smaller (pop < 100) communities will be paired with adjacent community as a site

Activities Oncho Impact Assessment Survey Tools and Samples Tools Skin snip test, Ov16 rapid test, Ov16 ELISA Skin snip up to 300 samples per site (adults 20yrs) Ov16 rapid test all children < 10yrs for each site Ov16 ELISA for 10% of children < 10yrs as quality control and compare sensitivity and specificity of Ov16 rapid test Entomology Blackfly breeding sites survey Blackfly collection for vector species identification and transmission assessment

Ov16 Prevalence by endemicity MF Prevalence by endemicity

Oncho Entomology Total Sites Visited Sites where eggs, Larvae, Nymph were collected Preliminary Results 267 37 11 sites (S. damnosum ) 26 sites (other species) Remarks Most sites on the major rivers were flooded and some inaccessible.

Salient outcomes of GOEC Meeting 120 oncho districts 82 biannual oncho districts Programme to conduct the pilot OEM survey

Delineation exercise Using the 20km flight rate, a delineation exercise was conducted in consultation with the districts A follow up - CDD training was done in districts to facilitate MDA

Achievement Oncho 2

MDA data and Coverage by region - 2017 1400000 1200000 1000000 800000 600000 400000 200000 0 82.6 82.5 82.1 84.6 80.6 83.5 81.8 85.3 85.9 87 86 85 84 83 82 81 80 79 78 77 Popu # Treated Coverage

Cont - MDA data- LF/Oncho 6 000 000 5 000 000 5 522 334 83.5% 4 611 541 4 000 000 3 000 000 83.2% 2 000 000 1 000 000 1 225 091 1 019 362 - LF Total population Oncho Total Number treated

800000 700000 MDA REGISTRATION/TREATMENT BY GENDER 2018 male registred female registred male treated female treated 600000 # REISTRED AND TREATED 500000 400000 300000 200000 100000 0 Ashanti Brong-Ahafo Central Eastern Northern Upper East Upper West Volta Western male registred 579608 516545 252844 464153 214246 148006 209402 411670 773978 female registred 620423 535012 269327 510688 232691 162678 228761 445555 798954 male treated 486102 433185 207533 390400 178802 127817 171529 354952 667427 female treated 518141 442483 219645 430402 193760 137072 186894 381819 682954 REGIONS

900000 800000 700000 MDA REGISTERED/TREATMENT BY GENDER 2018 male registred female registred 85.3 male treated female treated Coverage 85.9 85.9 87.0 86.0 85.0 # registered /treated 600000 500000 400000 300000 83.7 83.3 81.8 84.2 83.4 81.8 84.0 Coverages 83.0 82.0 200000 81.0 100000 80.0 0 Ashanti Brong-Ahafo Central Eastern Northern Upper East Upper West Volta Western male registred 579608 516545 252844 464153 214246 148006 209402 411670 773978 female registred 620423 535012 269327 510688 232691 162678 228761 445555 798954 male treated 486102 433185 207533 390400 178802 127817 171529 354952 667427 female treated 518141 442483 219645 430402 193760 137072 186894 381819 682954 Coverage 83.7 83.3 81.8 84.2 83.4 85.3 81.8 85.9 85.9 region 79.0

MDA Data-2018 1800000 Coverage 87.0 1600000 85.9 85.9 86.0 1400000 85.3 85.0 # registered/treated 1200000 1000000 800000 83.7 83.3 84.2 83.4 84.0 83.0 Coverages 600000 81.8 81.8 82.0 400000 81.0 200000 80.0 0 Ashanti Brong-Ahafo Central Eastern Northern Upper East Upper West Volta Western 1200031 1051557 522171 974841 446937 310684 438163 857225 1572932 1004243 875668 427178 820802 372562 264889 358423 736771 1350381 Coverage 83.7 83.3 81.8 84.2 83.4 85.3 81.8 85.9 85.9 Axis Title 79.0

Geographic Coverage by Disease-2018 12000 100.00 99.96 10541 10536 99.95 10000 99.90 8000 99.85 6000 99.80 4000 99.73 99.75 2283 2282 99.70 2000 99.65 0 LF Ocho 99.60 # of Communities # Communities treated Geo. Cov. (%)

Collaboration with research institutions UHAS (University of Health & Allied Sciences) KCCR (Kumasi Centre for Collaborative Research) of KNUST

Collaboration with Research unit of UHAS An open-label study of the pharmacokinetics and safety of a single dose of moxidectin per oral in participants aged 4 to 17 years with (or at high risk of) Onchocerca volvulus infection Safety and efficacy of combination therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) for individuals with onchocerciasis A Randomized, Double Blind, Parallel Group study to investigate Emodepside (BAY 44-4400) in Comparison to Ivermectin in Patients with Onchocerca volvulus Infection

Past Collaboration with KCCR Assessments of the transmission of Onchocerca volvulus by Simulium sanctipauli in the Upper Denkyira District, Ghana, and the intermittent disappearance of the vector

Ongoing Collaboration with KCCR Tackling the Obstacles of Filariasis

Cont Work-packages: Research task 1 Establishing a Filariasis Clinical Trial and Research Platform Research task 2: Rapid assessment of lymphedema burden using mobile phone based text messages by community health workers Research task 3: Reducing the daily dose of doxycycline to successfully treat filarial LE - a multinational, randomized, controlled non-inferiority trial Research task 4: Efficacy of ultrasound-guided hydrocele aspiration to prevent surgical intervention Research task 5: Comparing cost benefit ratios of test and treat approaches with the macrofilaricide doxycycline vs MDA with IVM/ALB for regional elimination of LF

KCCR - Future work awaiting approval Morbidity Management and surveillance of pathology of lymphatic filariasis using mobile phone-based tool by community health volunteers (CHVs) in Ghana

Challenges CDD apathy Community Inertia Weak monitoring and supervision Insecurity during field visits Cross border issues Population movement Synchronizing activities with neighbouring countries Retirement of highly skilled staff Decreasing political commitment

Way Forward Need for research evidence to guide hot spots?? Formal request for police service security in some areas Engage the HR division to recruit some category of staff Strengthen monitoring and supervision, especially at remote areas

Cont Synchronization of MDAs with neighbouring countries Strengthen monitoring and supervision, especially in remote areas Improve CDD motivation

Acknowledgements WHO USAID/FHI360 Sightsavers CouNTDown/DFID CNTD/DFID PATH Ghana Education Service Regions and districts CDDs and Communities